Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of Treatment in Slovene Follicular Lymphoma Patients.
Južnič Šetina T, Borštnar S, Jezeršek Novaković B. Južnič Šetina T, et al. Among authors: borstnar s. Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):586-91. doi: 10.1016/j.clml.2015.07.631. Epub 2015 Aug 3. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26423702 Free article.
A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.
Gennari A, Sun Z, Hasler-Strub U, Colleoni M, Kennedy MJ, Von Moos R, Cortés J, Vidal MJ, Hennessy B, Walshe J, Parraga KA, Ribi K, Bernhard J, Murillo SM, Pagani O, Barbeaux A, Borstnar S, Rabaglio-Poretti M, Maibach R, Regan MM, Jerusalem G; International Breast Cancer Study Group, Cancer Trials Ireland and SOLTI Group. Gennari A, et al. Among authors: borstnar s. Ann Oncol. 2018 Mar 1;29(3):661-668. doi: 10.1093/annonc/mdx772. Ann Oncol. 2018. PMID: 29228091 Free article. Clinical Trial.
Invasive bladder cancer: our experience with bladder sparing approach.
Cervek J, Cufer T, Zakotnik B, Kragelj B, Borstnar S, Matos T, Zumer-Pregelj M. Cervek J, et al. Among authors: borstnar s. Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):273-8. doi: 10.1016/s0360-3016(98)00013-3. Int J Radiat Oncol Biol Phys. 1998. PMID: 9607341
Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer - results from a real-world setting.
KovaČ A, Matos E, Kuhar CG, Čakš M, Ovčariček T, Mencinger M, Humar M, Borštnar S. KovaČ A, et al. Among authors: borstnar s. Cancer Treat Res Commun. 2020;25:100201. doi: 10.1016/j.ctarc.2020.100201. Epub 2020 Aug 27. Cancer Treat Res Commun. 2020. PMID: 32979704 Free article.
53 results